BIOTRICITY INC. (BTCY) — Quarterly Report

Key Insights

• The company's revenue from device sales and technology fees has shown steady growth over the past year, indicating strong demand for its products.
• The company has taken on additional debt financing through a new convertible note, which could provide capital to fund future operations and growth.
• The company has seen an increase in its Series B convertible redeemable preferred stock, which may indicate investor interest and confidence in the company's prospects.